Other - Other
Anti-IgE terapija astme i alergijskog rinitisa omalizumabom
Acta Pharmaceutica, 55 (2005), 2; 123-138. urn:nbn:hr:163:360976

Dodig, Slavica; Richter, Darko; Cepelak, Ivana; Benko, Bojan

Cite this document

Dodig, S., Richter, D., Cepelak, I. & Benko, B. (2005). Anti-IgE terapija astme i alergijskog rinitisa omalizumabom. Acta Pharmaceutica, 55. (2), 123-138. Retrieved from https://urn.nsk.hr/urn:nbn:hr:163:360976

Dodig, Slavica, et al. "Anti-IgE terapija astme i alergijskog rinitisa omalizumabom." Acta Pharmaceutica, vol. 55, no. 2, 2005, pp. 123-138. https://urn.nsk.hr/urn:nbn:hr:163:360976

Dodig, Slavica, Darko Richter, Ivana Cepelak and Bojan Benko. "Anti-IgE terapija astme i alergijskog rinitisa omalizumabom." Acta Pharmaceutica 55, no. 2 (2005): 123-138. https://urn.nsk.hr/urn:nbn:hr:163:360976

Dodig, S., et al. (2005) 'Anti-IgE terapija astme i alergijskog rinitisa omalizumabom', Acta Pharmaceutica, 55(2), pp. 123-138. Available at: https://urn.nsk.hr/urn:nbn:hr:163:360976 (Accessed 14 April 2024)

Dodig S, Richter D, Cepelak I, Benko B. Anti-IgE terapija astme i alergijskog rinitisa omalizumabom. Acta Pharmaceutica [Internet]. 2005 [cited 2024 April 14];55(2):123-138. Available at: https://urn.nsk.hr/urn:nbn:hr:163:360976

S. Dodig, D. Richter, I. Cepelak and B. Benko, "Anti-IgE terapija astme i alergijskog rinitisa omalizumabom", Acta Pharmaceutica, vol. 55, no. 2, pp. 123-138, 2005. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:163:360976. [Accessed: 14 April 2024]